Firm wielding Theranos patents asks judge to block coronavirus test
Found on Ars Technica on Wednesday, 18 March 2020
Back in 2018, the disgraced biotech company Theranos sold its patent portfolio to Fortress Investment Group, a division of Softbank. Now two of those patents have wound up in the hands of a little-known firm called Labrador Diagnostics—and Labrador is suing a company called BioFire Diagnostics that makes medical testing equipment.
As Stanford patent scholar Mark Lemley puts it, "this could be the most tone-deaf IP suit in history."
The patent system still needs to be fixed.